Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000019617-25-001004·JPMORGAN CHASE & CO
Schedule 13G ownership disclosure
Karyopharm Therapeutics Inc
Common Stock, $0.0001 par value · CUSIP: 48576U205
Event date: 2025-09-30
- Filing-level shares
- 427,624.0
- Percent of class
- 4.9%
- JPMORGAN CHASE & CO.
Shares: 427,624.0 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000019617-25-001004
- Form type
- SCHEDULE 13G/A
- Filer
- JPMORGAN CHASE & CO
- CIK
- CIK 19617
- Filed
- Oct 17, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership